Researchers, Labs and Groups
The Ottawa Hospital Research Institute includes more than 200 research labs and groups, 150 basic and clinical scientists and 700 clinician investigators, along with trainees and staff. Use the search tool below to find them or browse our Directory of Diseases and Research Approaches.
150
These researchers hold PhDs, MDs, MD/PhDs, or other regulated health professional designations and devote 40-100 per cent of their time to research. OHRI scientists are also professors at the University of Ottawa, and many are clinicians at The Ottawa Hospital. They are expected to secure major peer-reviewed grants and supervise trainees and often lead teams that include technicians and coordinators.
742
These researchers are generally physicians, nurses, or other regulated health professionals at The Ottawa Hospital who devote less than 40 per cent of their time to clinical research. They may also be professors at the University of Ottawa.
4
These individuals are typically PhD-trained with several years of postdoctoral experience. Core Investigators devote a portion of their time to research and are employed within an OHRI core facility. Departmental Investigators devote the majority of their time to research as an employee of a Department/Division at The Ottawa Hospital.
12
These are researchers who have made outstanding contributions to the success of OHRI.
167
These are researchers who have primary affiliations with other institutions but maintain collaborations with OHRI.
200+
These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team. Groups and labs can span the full spectrum of research from discovery to clinical research to implementation, or they may focus on one aspect.
Our research programs
Our core facilities
OHRI provides state-of-the-art core research facilities and platforms to internal and external users. These platforms are fueling world-class research in areas ranging from genomics and proteomics, to cell and virus manufacturing, to clinical trials and epidemiological studies.